fingolimod hydrochloride has been researched along with MPTP Neurotoxicity Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boguszewski, PM; Kosson, P; Motyl, J; Przykaza, Ł; Strosznajder, JB | 1 |
| Dagli, TC; Falkenburger, BH; Habib, P; Komnig, D; Schulz, JB; Zeyen, T | 1 |
| Hao, L; Hua, J; Li, L; Liu, L; Shi, D; Sun, X; Yao, S; Zhang, K; Zhou, H | 1 |
3 other study(ies) available for fingolimod hydrochloride and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Pramipexole and Fingolimod exert neuroprotection in a mouse model of Parkinson's disease by activation of sphingosine kinase 1 and Akt kinase.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; bcl-Associated Death Protein; Brain; Fingolimod Hydrochloride; Male; Mice; MPTP Poisoning; Neuroprotection; Parkinson Disease; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Pramipexole; Proto-Oncogene Proteins c-akt; Rotarod Performance Test; Tyrosine 3-Monooxygenase | 2018 |
Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor.
Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Brain-Derived Neurotrophic Factor; Dopamine; Dopaminergic Neurons; Fingolimod Hydrochloride; Humans; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Transgenic; MPTP Poisoning; Negative Results; Neuroprotective Agents; Parkinson Disease, Secondary; Substantia Nigra | 2018 |
FTY720 Inhibits MPP
Topics: Animals; Antiparkinson Agents; Apoptosis; Cell Line; Corpus Striatum; Cytokines; Dopaminergic Neurons; Drug Evaluation, Preclinical; Exploratory Behavior; Fingolimod Hydrochloride; Inflammasomes; Male; Mice; Mice, Inbred C57BL; Microglia; Mitochondria; MPTP Poisoning; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; Parkinsonian Disorders; Pars Compacta; Reactive Oxygen Species; Rotarod Performance Test; Signal Transduction | 2019 |